Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NWBO - Northwest Biotherapeutics secures $15M financing on stock purchase rights

NWBO - Northwest Biotherapeutics secures $15M financing on stock purchase rights

Northwest Biotherapeutics Inc.
Northwest Biotherapeutics (OTCQB:NWBO +12.3%) has closed on $15M financing, which brings the company's cash reserves above $20M. The financing is in the form of a 22-month loan which requires no payments for 8 months, and then provides for a subsequent 14-month amortization period. Interest rate is 8% p.a. In addition, the terms allow lender to exchange outstanding loan balance with the company's common shares at discounted rates just following the release of top line data from the Northwest's Phase III clinical trial of DCVax®-L for Glioblastoma brain cancer. The company says it plans to use the funds to help accelerate its activities related to its brain cancer program. Press Release

For further details see:

Northwest Biotherapeutics secures $15M financing on stock purchase rights
Stock Information
Company Name: Northwest Biotherapeutics Inc.
Stock Symbol: NWBO
Market: OTC
Website: nwbio.com
Menu
NWBO NWBO Quote NWBO Short NWBO News NWBO Articles NWBO Message Board
Get NWBO Alerts

News, Short Squeeze, Breakout and More Instantly...